Myomectomy is a surgery to remove uterine fibroids, which are non-cancerous growths that develop in the muscular walls of the uterus. While this operation is commonly performed in many countries, practices and availability of myomectomy varies significantly depending on location. Let's take a look at how this procedure is approached globally.
United States
In the United States, myomectomy is a widely available option for women with symptomatic fibroids. It is most commonly performed using a minimally invasive approach such as laparoscopy rather than traditional open abdominal surgery. This allows for smaller incisions, less blood loss, shorter hospital stays and quicker recovery times compared to open myomectomy.
The number of minimally invasive myomectomies has grown in the US in recent years. According to a study analyzing national trends from 2006 to 2015, the use of robotic-assisted laparoscopic myomectomy jumped from 1.4% to 23.5% during that time period. Regional differences in technique exist, for instance laparoscopy is more commonly used on the East and West coasts compared to the Midwest where open surgery remains slightly more frequent.
Overall, Myomectomy has become a standard treatment for appropriately selected patients with uterine fibroids in the US healthcare system which utilizes an advanced approach with robotic technology widely available at major medical centers nationwide. Insurance coverage helps make this an accessible option for many American women.
Myomectomy Industry in United Kingdom
In the UK’s national healthcare system, myomectomy is generally offered when fibroids are causing heavy periods, pain or pressure symptoms that significantly impact quality of life. National guidelines consider it a suitable treatment for women wishing to preserve their uterus and fertility.
Similar to the US, laparoscopic and robotic myomectomy are becoming increasingly common techniques used by gynecological surgeons in the UK. A 2019 study found the laparoscopic approach was utilized in over 70% of cases at their institution.
Some regional differences do exist within the UK based on local practices and resources. Women in rural areas may have less accessibility to minimally invasive options depending on the facilities and surgeon experience available nearby. Despite this, myomectomy remains widely accessible to eligible patients across the country through Britain's universal healthcare model.
Get More Insights on- Myomectomy
For Deeper Insights, Find the Report in the Language that You want:
